Vitreous fluorophotometry in diabetes mellitus

Area of Science:

• Ophthalmology
• Endocrinology
• Medical Diagnostics

Background:

• Diabetes mellitus is a systemic disease with significant ocular complications.
• The integrity of the blood-ocular barrier is crucial for maintaining ocular health.
• Early detection of ocular abnormalities in diabetes is essential for timely intervention.

Purpose of the Study:

• To evaluate the utility of vitreous fluorophotometry in assessing the blood-ocular barrier in diabetes.
• To determine if fluorescein leakage into the vitreous is an early indicator of diabetic eye disease.
• To investigate the reversibility of this ocular abnormality.

Main Methods:

• Vitreous fluorophotometry was used to measure fluorescein accumulation in the vitreous humor.
• Studies were conducted in both human diabetic patients and streptozotocin-induced diabetic rats.
• Interventions included insulin therapy and pancreatic islet transplantation in the rat model.

Main Results:

• Diabetic patients, with or without retinopathy, showed increased vitreous fluorescein compared to controls.
• Diabetic rats exhibited elevated vitreous fluorescein levels.
• Insulin therapy and islet transplantation reversed the increased vitreous fluorescein in rats.

Conclusions:

• Breakdown of the blood-ocular barrier to fluorescein is the earliest detectable ocular abnormality in diabetes.
• Vitreous fluorophotometry is a valuable tool for assessing diabetic ocular complications.
• The observed abnormality is potentially reversible with diabetes management.